- Home
- NURO vs ADIL Comparison
NURO vs ADIL Comparison
Compare NURO & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NURO
- ADIL
- Stock Information
- Founded
- NURO 1996
- ADIL 2010
- Country
- NURO United States
- ADIL United States
- Employees
- NURO N/A
- ADIL N/A
- Industry
- NURO Medical/Dental Instruments
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- NURO Health Care
- ADIL Health Care
- Exchange
- NURO Nasdaq
- ADIL Nasdaq
- Market Cap
- NURO 7.6M
- ADIL 6.5M
- IPO Year
- NURO N/A
- ADIL 2018
- Fundamental
- Price
- NURO $3.86
- ADIL $1.12
- Analyst Decision
- NURO
- ADIL Strong Buy
- Analyst Count
- NURO 0
- ADIL 1
- Target Price
- NURO N/A
- ADIL $8.00
- AVG Volume (30 Days)
- NURO 23.4K
- ADIL 203.6K
- Earning Date
- NURO 11-05-2024
- ADIL 11-13-2024
- Dividend Yield
- NURO N/A
- ADIL N/A
- EPS Growth
- NURO N/A
- ADIL N/A
- EPS
- NURO N/A
- ADIL N/A
- Revenue
- NURO $3,767,764.00
- ADIL N/A
- Revenue This Year
- NURO N/A
- ADIL N/A
- Revenue Next Year
- NURO N/A
- ADIL N/A
- P/E Ratio
- NURO N/A
- ADIL N/A
- Revenue Growth
- NURO N/A
- ADIL N/A
- 52 Week Low
- NURO $2.66
- ADIL $0.77
- 52 Week High
- NURO $4.73
- ADIL $4.17
- Technical
- Relative Strength Index (RSI)
- NURO 51.55
- ADIL 55.23
- Support Level
- NURO $3.63
- ADIL $1.05
- Resistance Level
- NURO $4.07
- ADIL $1.27
- Average True Range (ATR)
- NURO 0.24
- ADIL 0.09
- MACD
- NURO -0.03
- ADIL -0.00
- Stochastic Oscillator
- NURO 56.09
- ADIL 46.88
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.